Posts in: press release (3)

eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health
press releaseinvestornutraceuticalsmedicinescience
eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver healthMay 6, 2025
Dr. Tyler Korman, co-founder and VP of Research at eXoZymes, is excited about the 'exozymes' cover story in GEN Biotechnology, which is freely available as an Open Access paper.
press releaseinvestorvideoscienceARCHIVE
ARCHIVE: GEN Biotechnology cover story: Bringing clarity and precision to the cell-free space by introducing exozymesApril 21, 2025
BioClick - an enzyme engineering game-changer
press releaseinvestorscienceARCHIVE
ARCHIVE: BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grantApril 10, 2025
ARCHIVE: eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
talentpress releaseinvestorvideoARCHIVEperriman
ARCHIVE: eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCOApril 2, 2025
ARCHIVE: eXoZymes Provides Fourth Quarter and Full Year 2024 Update
press releaseinvestorARCHIVE
ARCHIVE: eXoZymes Provides Fourth Quarter and Full Year 2024 UpdateApril 2, 2025
ARCHIVE: eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025
press releaseIPOinvestorARCHIVE
ARCHIVE: eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025March 26, 2025
Edgardo Rayo, new member of the Board of Directors at eXoZymes Inc.
press releaseinvestorARCHIVE
ARCHIVE: eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.February 21, 2025
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering on Feb 19, 2025
press releaseIPOinvestorARCHIVE
ARCHIVE: Nasdaq Bell Ringing to Commemorate Initial Public OfferingFebruary 19, 2025
ARCHIVE: Rebranding Invizyne to eXoZymes signifies a sustainable paradigm shift in chemical production leveraging AI-engineered enzymes
press releaseinvestorARCHIVE
ARCHIVE: Rebranding Invizyne to eXoZymes signifies a sustainable paradigm shift in chemical production leveraging AI-engineered enzymesFebruary 12, 2025
ARCHIVE: Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol
press releaseinvestorARCHIVE
ARCHIVE: Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker SymbolFebruary 10, 2025
Previous page
Page 3 of 5
Next page